Fingerprint
Dive into the research topics of 'Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer
CANTATA investigators
Research output: Contribution to journal › Article › peer-review
45
Downloads
(Pure)